High plasma citrulline and arginine levels ensured by sustained-release citrulline supplementation in rats

Nutrition

Volumn 27, Issue 11-12, 2011, Pages 1168-1171

  Berthe, Marie Clotilde ^a,b   Darquy, Sylviane ^a   Breuillard, Charlotte ^a   Lamoudi, Lynda ^a,c   Marc, Julie ^a   Cynober, Luc ^a,d   Chaumeil, Jean Claude ^a   Couderc, Rémy ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^d HÔTEL DIEU   (France)

Author keywords

Cardiovascular disease; Rat; Sustained release citrulline

Indexed keywords

ARGININE; CITRULLINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ARGININE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CITRULLINE BLOOD LEVEL; CITRULLINEMIA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG FORMULATION; HYPERARGININEMIA; IMMEDIATE RELEASE FORMULATION; MALE; MORNING DOSAGE; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED RELEASE FORMULATION;

ANIMALS; ARGININE; CARDIOVASCULAR DISEASES; CITRULLINE; DELAYED-ACTION PREPARATIONS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERARGININEMIA; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 80053450579     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.12.004     Document Type: Article

References (24)

1. Flam B.R., Hartmann P.J., Harrell-Booth M., Solomonson L.P., Eichler D.C. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 2001, 5:187-197.
2. Goodwin B.L., Solomonson L.P., Eichler D.C. Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J Biol Chem 2004, 279:18353-18360.
3. Solomonson L.P., Flam B.R., Pendleton L.C., Goodwin B.L., Eichler D.C. The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. J Exp Biol 2003, 206:2083-2087.
4. Romero M.J., Platt D.H., Caldwell R.B., Caldwell R.W. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev 2006, 24:275-290.
5. Osowska S., Moinard C., Neveux N., Loi C., Cynober L. Citrulline increases arginine pools and restores nitrogen balance after massive intestinal resection. Gut 2004, 53:1781-1786.
6. Hayashi T., Juliet P.A., Matsui-Hirai H., Miyazaki A., Fukatsu A., Funami J., et al. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 2005, 102:13681-13686.
7. Wu G., Collins J.K., Perkins-Veazie P., Siddiq M., Dolan K.D., Kelly K.A., et al. Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr 2007, 137:2680-2685.
8. Moinard C., Nicolis I., Neveux N., Darquy S., Benazeth S., Cynober L. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr 2008, 99:855-862.
9. Rouge C., Des Robert C., Robins A., Le Bacquer O., Volteau C., De La Cochetiere M.F., et al. Manipulation of citrulline availability in humans. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1061-G1067.
10. Cynober L. Pharmacokinetics of arginine and related amino acids. J Nutr 2007, 137:1646S-1649S.
11. Barr F.E., Tirona R.G., Taylor M.B., Rice G., Arnold J., Cunningham G., et al. Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension. J Thorac Cardiovasc Surg 2007, 134:319-326.
12. Smith H.A., Canter J.A., Christian K.G., Drinkwater D.C., Scholl F.G., Christman B.W., et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. J Thorac Cardiovasc Surg 2006, 132:58-65.
13. Jourdan M., Nair K.S., Ford C., Shimke J., Ali B., Will B., et al. Citrulline stimulates muscle protein synthesis at the post-absorptive sate in healthy subjects fed a low-protein diet. Clin Nutr Suppl 2008, 3:11S-12S.
14. Mezreb N., Charrueau C., Boy P., Allain P., Chaumeil J.C. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization: optimization of the processing parameters and water content. Drug Dev Ind Pharm 2004, 30:481-490.
15. Neveux N., David P., Cynober L. Measurement of amino acid concentrations in biological fluids and tissues ursing ion exchange chromatography. Metabolic and therapeutics aspects of amino acids in clinical nutrition 2004, CRC Press, Boca Raton. L.A. Cynober (Ed.).
16. Gewaltig M.T., Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002, 55:250-260.
17. Liu V.W., Huang P.L. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 2008, 77:19-29.
18. Preli R.B., Klein K.P., Herrington D.M. Vascular effects of dietary L-arginine supplementation. Atherosclerosis 2002, 162:1-15.
19. Schwedhelm E., Maas R., Freese R., Jung D., Lukacs Z., Jambrecina A., et al. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 2008, 65:51-59.
20. Bardel A., Wallander M.A., Svardsudd K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol 2007, 63:307-314.
21. Boger G.I., Rudolph T.K., Maas R., Schwedhelm E., Dumbadze E., Bierend A., et al. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: effect of combination with oral L-arginine. J Am Coll Cardiol 2007, 49:2274-2282.
22. Miller A.L. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals. Altern Med Rev 2006, 11:23-29.
23. Grimble G.K. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr 2007, 137:1693S-1701S.
24. Siasos G., Tousoulis D., Antoniades C., Stefanadi E., Stefanadis C. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?. Int J Cardiol 2007, 116:300-308.